X4 Pharmaceuticals (XFOR) Acquisitions (2019)
X4 Pharmaceuticals' (XFOR) quarterly Acquisitions came in at $52.8 million in Q4 2019, up 300.0% on a QoQ basis from -$26.4 million in Q1 2019.
X4 Pharmaceuticals (XFOR) Acquisitions (2019) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 1 years of Acquisitions data on file, last reported at $52.8 million in Q4 2019.
- Quarterly Acquisitions changed N/A year-over-year to $52.8 million in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $52.8 million (up 300.0% YoY) and the FY2019 annual result came in at $26.4 million, changed N/A from the prior year.
- Acquisitions climbed to $52.8 million in Q4 2019, from -$26.4 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $52.8 million in Q4 2019 to a low of -$26.4 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 52.81 Mn |
| Mar 31, 2019 | -26.41 Mn |